BNTC icon

Benitec Biopharma

37 hedge funds and large institutions have $290M invested in Benitec Biopharma in 2025 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
+7
Holders Change %
+23.33%
% of All Funds
0.5%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
10
Increased
16
Reduced
6
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
State Street
26
State Street
Massachusetts
$276K +$66.4K +5,100 +32%
Qube Research & Technologies (QRT)
27
Qube Research & Technologies (QRT)
United Kingdom
$247K -$24.6K -1,893 -9%
UBS Group
28
UBS Group
Switzerland
$130K +$65K +4,999 +100%
SG Americas Securities
29
SG Americas Securities
New York
$110K +$110K +8,458 New
Citigroup
30
Citigroup
New York
$80.1K -$82.1K -6,308 -51%
GI
31
GAMMA Investing
California
$77.6K -$6.23K -479 -7%
Balyasny Asset Management
32
Balyasny Asset Management
Illinois
$36.6K +$36.6K +2,816 New
Acadian Asset Management
33
Acadian Asset Management
Massachusetts
$23K +$23K +1,817 New
Bank of America
34
Bank of America
North Carolina
$3.8K +$1.87K +144 +97%
Royal Bank of Canada
35
Royal Bank of Canada
Ontario, Canada
$3K +$505 +35 +20%
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$2.42K
Group One Trading
37
Group One Trading
Illinois
$1.16K
6CM
38
683 Capital Management
New York
-$452K -35,817 Closed
TRCT
39
Tower Research Capital (TRC)
New York
-$13.9K -1,099 Closed
NA
40
NewEdge Advisors
Louisiana
-$8.48K -671 Closed